SNHG4 and chronic obstructive pulmonary disease: Importantly, the downregulation of FHL1 offsets the beneficial effects of SNHG4 on CSE-treated HBE cells, indicating SNHG4 mediates COPD progression by targeting the miR-409-3p/FHL1 axis.